Zhejiang Benli Technology Co. Ltd. (301065) - Total Liabilities

Latest as of March 2026: CN¥241.20 Million CNY ≈ $35.30 Million USD

Based on the latest financial reports, Zhejiang Benli Technology Co. Ltd. (301065) has total liabilities worth CN¥241.20 Million CNY (≈ $35.30 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 301065 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Zhejiang Benli Technology Co. Ltd. - Total Liabilities Trend (2019–2025)

This chart illustrates how Zhejiang Benli Technology Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Zhejiang Benli Technology Co. Ltd. balance sheet assets.

Zhejiang Benli Technology Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Zhejiang Benli Technology Co. Ltd. ranked by their total liabilities.

Company Country Total Liabilities
Guangzhou Improve Med Instrument
SHE:300030
China CN¥346.01 Million
Vinacafe Bien Hoa JSC
VN:VCF
Vietnam ₫588.19 Billion
Fortress Value Acquisition Corp. V Class A Ordinary Shares
NASDAQ:FVAV
USA $17.18 Million
Seah Steel Corp
KO:003030
Korea ₩3.62 Trillion
Joyvio Agriculture Development Co Ltd
SHE:300268
China CN¥1.36 Billion
WCM Beteiligungs- und Grundbesitz-AG
F:WCMK
Germany €54.32 Million
Zhejiang Dilong New Material Co Ltd
SHE:002247
China CN¥281.35 Million
Multilaser Industrial SA
SA:MLAS3
Brazil R$2.17 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Zhejiang Benli Technology Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Zhejiang Benli Technology Co. Ltd.'s balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.54 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Benli Technology Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Benli Technology Co. Ltd. (2019–2025)

The table below shows the annual total liabilities of Zhejiang Benli Technology Co. Ltd. from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥279.13 Million
≈ $40.85 Million
-12.05%
2024-12-31 CN¥317.36 Million
≈ $46.44 Million
+62.66%
2023-12-31 CN¥195.10 Million
≈ $28.55 Million
+32.24%
2022-12-31 CN¥147.54 Million
≈ $21.59 Million
+1.83%
2021-12-31 CN¥144.89 Million
≈ $21.20 Million
-13.57%
2020-12-31 CN¥167.63 Million
≈ $24.53 Million
+5.78%
2019-12-31 CN¥158.47 Million
≈ $23.19 Million
--

About Zhejiang Benli Technology Co. Ltd.

SHE:301065 China Chemicals
Market Cap
$296.47 Million
CN¥2.03 Billion CNY
Market Cap Rank
#14999 Global
#4465 in China
Share Price
CN¥19.11
Change (1 day)
+0.42%
52-Week Range
CN¥16.81 - CN¥24.84
All Time High
CN¥51.11
About

Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sales of pharmaceutical, pesticide, and new material intermediates in China and internationally. Its products include 2,4-Dichloro-5-fluorobenzoyl chloride, 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamine ethyl acrylate, 1-Ethyl-7-(1-piperazinyl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hy… Read more